for more than 25 years and served on various boards, including
Commerce Exchange Bank and Southwest General Hospital. As a board
member of Commerce Exchange Bank, he was instrumental in raising share
value of the stock from $2.00 to a sale price of $13.00. He presently
is a director on the Systems Board at Southwest General Hospital, a
multi-million dollar company.
-- Lewis White, a major shareholder in Biomoda, is director and CEO of
New Energies Nebraska, LLC, a subsidiary of Standard Alcohol Company.
He has also served as CEO of Los Hojas Corporation and owned a
successful childcare business for 20 years, which he followed with an
interest in business investment through real estate and a thriving
food services business catering to niche markets. White attended the
University of Nebraska at Omaha where majored in Business
Administration and worked for the State of Nebraska.
With Biomoda's technology, clinicians can identify cancerous or aberrant cells extracted from samples of lung sputum; cancerous cells glow red under fluorescent light and can be detected under a microscope. Current diagnostic methods for lung cancer, including CT scans and X-rays, often detect the disease at more advanced stages. Biomoda's technology complements these tools by screening for signs of lung cancer at an earlier stage, ensuring that patients receive advanced tests at the appropriate time.
Earlier this year, Biomoda and the New Mexico Institute of Mining and
Technology announced their partnership with the New Mexico Department of
Veterans Services to conduct a $350,000 clinical study using Biomoda's
proprietary testing technology for detection of early lung cancer in the
state's veterans. The New Mexico state legislature recently allocated an
additional $1.3 million in funding through the Interim Tobacco Settlement
|SOURCE Biomoda, Inc.|
Copyright©2008 PR Newswire.
All rights reserved